ArticleAnnals of hematology2023

Correction to: Efficacy and safety of ixazomib plus lenalidomide and dexamethasone following injectable pi‑based therapy in relapsed/refractory multiple myeloma.

Yu Abe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.